Companion Animals

Canine Atopic Dermatitis: Long-Term Welfare Management

Comprehensive welfare guide for canine atopic dermatitis -- a chronic allergic skin disease causing lifelong itching and discomfort.

Key Facts

Canine atopic dermatitis affects an estimated 10-15% of dogs globally
It is caused by hypersensitivity to environmental allergens -- dust mites, pollens, and moulds
Clinical signs include itching, rubbing, licking, and repeated ear infections
Chronic pruritus causes significant welfare deterioration -- sleep disruption, anxiety, and secondary infections
Multiple treatment options now exist including Cytopoint (lokivetmab), Apoquel (oclacitinib), and allergen immunotherapy
Skin barrier dysfunction is increasingly recognised as a central mechanism -- barrier repair treatments support management
Environmental modifications reduce allergen load and improve welfare alongside medication
Atopic dogs require lifelong management -- there is no cure, but welfare can be excellently maintained

Welfare Significance

Canine atopic dermatitis causes chronic suffering from intense itching. The welfare burden extends beyond the skin -- sleep disruption, anxiety, and secondary infections all affect quality of life. Modern biologics like Cytopoint have transformed welfare outcomes for many atopic dogs, providing rapid and sustained itch relief without the side effects of long-term steroids.

What You Can Do

Seek veterinary diagnosis for any dog with chronic itching, ear infections, or skin lesions
Discuss modern itch-control options including Cytopoint and Apoquel with your vet
Implement allergen reduction measures -- frequent washing, dust-mite covers on bedding, HEPA filters
Consider allergen immunotherapy for long-term disease modification in suitable candidates